GGrantIndex
Sort

64,565 grants matching drug discovery

Utilizing genetic and functional strategies to identify causal genes and alleles

$488,427
Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2016 · GM

Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis

$488,421
Brigitte N Gomperts · University Of California Los Angeles · U01 · FY2021 · HL

IDU Peer Recruitment Dynamics and Network Structure in Respondent Driven Sampling

$488,409
Jianghong Li · Institute For Community Research · R01 · FY2011 · DA

Equipment: MRI: Track 1 Acquisition of a Cryo-enabled Scanning Electron Microscope for Research and Education at the Florida Institute of Technology and Partners.

$488,373
Andrew G Palmer · Florida Institute Of Technology · · FY2024 · ENG

Small Molecule Probes of the Neuropeptide S Receptor

$488,351
Scott P Runyon · Research Triangle Institute · R01 · FY2014 · MH

(PQD5) imaging systemic tissue injuries induced by anticancer drugs

$488,338
Ming Zhao · Northwestern University At Chicago · R01 · FY2014 · CA

PD-1/PD-L1 modulation in cancer therapy

$488,332
Drew M. Pardoll · Johns Hopkins University · R01 · FY2017 · CA

PD-1/PD-L1 modulation in cancer therapy

$488,332
Drew M. Pardoll · Johns Hopkins University · R01 · FY2016 · CA

PD-1/PD-L1 modulation in cancer therapy

$488,332
Drew M. Pardoll · Johns Hopkins University · R01 · FY2018 · CA

Developmental Funds

$488,257
Jennifer A Pietenpol · Vanderbilt University · P30 · FY2012 · CA

Synthesis of Anti-Infective Agents

$488,217
K. C. Nicolaou · Rice University · R01 · FY2013 · AI

Expanding the Chemical Biology of K2P Channels with Selective Cellular and In vivo Probes

$488,166
Adam R Renslo · University Of California, San Francisco · R01 · FY2018 · MH

Novel Therapeutics for FSHD - Resources Core - Core C

$488,071
Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2018 · HD

Role of microbially-derived metabolites in anti-tumor immunity in breast cancer

$488,057
Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · R01 · FY2025 · CA

Immobilized Proteins In Drug Discovery

$488,034
Josephine Earley · National Institute On Aging · ZIA · FY2019 · AG

Genetics and Biology of Pancreatic Duct Adenocarcinoma

$488,024
Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2009 · CA

GOALI: Informing Amorphous Formulations Design through Quantitative Nonlinear Optical Analysis

$488,000
Garth J Simpson · Purdue University · · FY2014 · MPS

Novel Molecular Determinants of Insulin Clearance

$487,992
Miklos Peterfy · Western University Of Health Sciences · R01 · FY2022 · DK

OST Inhibition in NSCLC

$487,978
Joseph N Contessa · Yale University · R01 · FY2021 · CA

OST Inhibition in NSCLC

$487,978
Joseph N Contessa · Yale University · R01 · FY2020 · CA

Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2

$487,972
Chang Liu · Johns Hopkins University · DP2 · FY2025 · AI

Elucidating mechanisms of SIRT1 activation

$487,967
David A. Sinclair · Harvard Medical School · R01 · FY2020 · DK

Molecular Analysis of Modular Polyketide Synthases

$487,950
David H Sherman · University Of Michigan At Ann Arbor · R01 · FY2013 · GM

Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer

$487,929
Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

Predicted Gene Expression: High Power, Mechanism, and Direction of Effect

$487,902
Hae Kyung Im · University Of Chicago · R01 · FY2015 · MH